Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors
RSC Medicinal Chemistry · 2026
DOI: 10.1039/d6md00652c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Zixuan Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical U…. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A novel series of triazole derivatives was synthesized via scaffold hopping. Compound CZ14 exhibited potent antifungal activity against Candida albicans , inhibiting yeast-to-hypha transition and biofilm formation.
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University 103 Wenhua Road, Shenhe District 110016 Shenyang China.
ORCID-Profile: Dongmei Zhao, Maosheng Cheng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, Z., Cui, C., Chen, M., Hao, W., Li, K., Fan, C., Luo, Z., Su, X., Zhao, D., & Cheng, M. (2026). Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00652c
Vancouver
Gao Z, Cui C, Chen M, Hao W, Li K, Fan C, et al. Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00652c
BibTeX
@article{Gao2026,
author = {Gao, Zixuan and Cui, Cancan and Chen, Mingshuo and Hao, Wenzhan and Li, Kejian and Fan, Cunzheng and Luo, Zirui and Su, Xin and Zhao, Dongmei and Cheng, Maosheng},
title = {Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors},
journal = {RSC Medicinal Chemistry},
year = {2026},
doi = {10.1039/d6md00652c}
}
EUVIMED